FDA Inspection
New York Presbyterian Hospital Weill Cornell Medical CollegeNew York Presbyterian Hospital Weill Cornell Medical College – FDA Inspection, Sep 28, 2016
Record Details
This FDA Inspection record concerns New York Presbyterian Hospital Weill Cornell Medical College, with an inspection on September 28, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 28, 2016
- Product Type
- Biologics
View Company Profile
ID · ce8f8886-fe1a-481d-95c9-de4d3030811a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 988710
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of New York Presbyterian Hospital Weill Cornell Medical College
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 18, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 25, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 25, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 14, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 20, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for New York Presbyterian Hospital Weill Cornell Medical College
- FDA Inspection 1309054 - 2026-03-18
- FDA Inspection 1211289 - 2023-07-25
- FDA Inspection 1109017 - 2019-09-25
- FDA Inspection 878683 - 2014-05-14
- FDA Inspection 794517 - 2012-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.